Bladder cancer Board decisions

The Board has found new and material evidence to reopen the claim of service connection for bladder cancer, which is presumed to be related to herbicide exposure in Vietnam. The appellant's bladder cancer was noted on a November 2004 VA Agent Orange examination report.

The Board has determined that the Veteran's bladder cancer is a direct result of his exposure to dioxin (Agent Orange) during service, and grants service connection for this condition.

The Veteran's appeal is remanded due to the need for additional development, including obtaining medical records and scheduling VA examinations.

The Board has determined that the Veteran's death was caused by his prostate cancer, which is presumed to have been incurred due to herbicide exposure during service in Vietnam. The cause of death is therefore granted.

The Veteran's death was due to VA's carelessness in diagnosing and treating his kidney cancer, leading to the development of metastatic bladder cancer. The Board found that the Veteran's additional disability (metastasis and death) was caused by VA's error in judgment or carelessness.

The Veteran's claim for service connection for bladder cancer, prostate cancer, and cancer of the abdominal wall is being remanded due to incomplete development. The VA will obtain records regarding possible radiation exposure during service and determine if there is a link between such exposure and his cancers.

The Board has remanded the claims for service connection of prostate cancer and bladder cancer for the purpose of accrued benefits, as well as the claim for cause of death. The Appellant must provide additional evidence or authorize VA to obtain relevant records, including medical records from Duke University Medical Center.

The Veteran's appeal is being remanded to accommodate his request for a Travel Board hearing at the RO.

The Veteran's appeal is being remanded for a Travel Board hearing at the RO. The issues of entitlement to service connection for bladder cancer and impotency, secondary to bladder cancer are still under consideration.

The Board denied the appellant's claims for service connection for the cause of the Veteran's death and accrued benefits. The Board found that there was no evidence to support a finding that any service-connected disability caused or contributed substantially or materially to the Veteran's death.

The Board has remanded the case for further development and readjudication. The Veteran is entitled to a Travel Board hearing.

The Veteran's residuals of bladder cancer, with erectile dysfunction, status post cystectomy due to radiation exposure, are currently rated at 60 percent and the appeal is granted.

The Board has remanded the case for additional development due to inadequate medical opinions and consideration of new evidence.

The Veteran's prostate and bladder cancers were not shown to be related to his active service, including exposure to Agent Orange. The Board found that the Veteran did not serve in Vietnam or have a presumptive exposure to herbicides.

The Veteran's bladder cancer was not incurred in or aggravated by service, including exposure to mustard gas. The Board found no evidence linking the current condition to his military service.

The Board has remanded the case due to incomplete records and further development is needed.

The Veteran's bladder cancer is presumed to be related to his exposure to Agent Orange during service in Vietnam. The claim for prostate disability and bilateral hearing loss remains pending.

The Veteran's bladder cancer is related to his service-connected urethritis and gonorrhea, which he experienced during active duty. The Board grants the claim for service connection on a direct basis.

The Board has remanded the appeal for additional development due to a VLJ's departure and the Veteran's request for another hearing.

The Board has remanded the case due to insufficient medical opinions regarding the cause of death and whether service-connected conditions contributed to it. The Veteran died from bladder cancer, but there is uncertainty about the type of cancer and whether his pre-existing conditions played a role.